Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
33 hedge funds and large institutions have $33.3M invested in Ocera Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 11 closing their positions.
8% less funds holding
Funds holding: 36 → 33 (-3)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
26% less capital invested
Capital invested by funds: $45.1M → $33.3M (-$11.8M)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
+$832K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$776K |
| 3 |
Millennium Management
New York
|
+$739K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$722K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$213K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$1.08M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$362K |
| 3 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$314K |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$296K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$289K |
OCRX Hedge Fund Activity: Q2 2014 in Review
33 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q2 2014, worth a combined $33.3M — down 26% from $45.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of OCRX and 8 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Pacific Alternative Asset Management Company (PAAMCO), adding an estimated $832K. The largest seller was Ghost Tree Capital, cutting an estimated $1.08M.
- 33 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q2 2014, down from 36 in Q1 2014.
- Funds reported $33.3M of Ocera Therapeutics, Inc. stock for Q2 2014, down 26% quarter-over-quarter.
- 8 funds opened new Ocera Therapeutics, Inc. positions in Q2 2014 and 11 closed out, a net change of -3 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q2 2014 was Pacific Alternative Asset Management Company (PAAMCO), an estimated $832K added.
- The largest Ocera Therapeutics, Inc. seller in Q2 2014 was Ghost Tree Capital, an estimated $1.08M sold.
Based on aggregated 13F filings for Q2 2014.